198 related articles for article (PubMed ID: 28406767)
21. Insulin resistance and oxidative marker in women with PCOS.
Bannigida DM; Nayak BS; Vijayaraghavan R
Arch Physiol Biochem; 2020 May; 126(2):183-186. PubMed ID: 30450993
[TBL] [Abstract][Full Text] [Related]
22. Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance.
Cupisti S; Häberle L; Dittrich R; Oppelt PG; Reissmann C; Kronawitter D; Beckmann MW; Mueller A
Fertil Steril; 2010 Jul; 94(2):673-7. PubMed ID: 19394003
[TBL] [Abstract][Full Text] [Related]
23. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
24. The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS.
Li X; Yang D; Pan P; Azziz R; Yang D; Cheng Y; Zhao X
Front Endocrinol (Lausanne); 2022; 13():873726. PubMed ID: 35769085
[TBL] [Abstract][Full Text] [Related]
25. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
Ezeh U; Pall M; Mathur R; Azziz R
Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
[TBL] [Abstract][Full Text] [Related]
26. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations.
Kauffman RP; Baker VM; Dimarino P; Gimpel T; Castracane VD
Am J Obstet Gynecol; 2002 Nov; 187(5):1362-9. PubMed ID: 12439532
[TBL] [Abstract][Full Text] [Related]
27. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
Legro RS; Castracane VD; Kauffman RP
Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of mtDNA in the D-loop region moderate the associations of BMI with HOMA-IR and HOMA-β among women with polycystic ovary syndrome: a cross-sectional study.
He S; Ji D; Liu Y; Deng X; Zou W; Liang D; Du Y; Zong K; Jiang T; Li M; Zhang D; Yue X; Tao F; Cao Y; Liang C
J Assist Reprod Genet; 2023 Aug; 40(8):1983-1993. PubMed ID: 37358742
[TBL] [Abstract][Full Text] [Related]
29. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
30. Lack of Fetal Insulin Resistance in Maternal Polycystic Ovary Syndrome.
Tobiasz AM; Duncan JR; Detti L; Mari G
Reprod Sci; 2020 Jun; 27(6):1253-1258. PubMed ID: 31994004
[TBL] [Abstract][Full Text] [Related]
31. Close correlation between hyperandrogenism and insulin resistance in women with polycystic ovary syndrome-Based on liquid chromatography with tandem mass spectrometry measurements.
Yang Y; Ding M; Di N; Azziz R; Yang D; Zhao X
J Clin Lab Anal; 2019 Mar; 33(3):e22699. PubMed ID: 30350882
[TBL] [Abstract][Full Text] [Related]
32. The frequency of insulin resistance calculated upon the basis of a fasting glucose to insulin ratio and characteristics of insulin resistant women with polycystic ovary syndrome.
Popovska-Dimova Z; Krstevska B
Prilozi; 2006 Jul; 27(1):87-95. PubMed ID: 16985482
[TBL] [Abstract][Full Text] [Related]
33. Sleep Duration, Exercise, Shift Work and Polycystic Ovarian Syndrome-Related Outcomes in a Healthy Population: A Cross-Sectional Study.
Lim AJ; Huang Z; Chua SE; Kramer MS; Yong EL
PLoS One; 2016; 11(11):e0167048. PubMed ID: 27870902
[TBL] [Abstract][Full Text] [Related]
34. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.
Song do K; Lee H; Sung YA; Oh JY
Yonsei Med J; 2016 Nov; 57(6):1404-11. PubMed ID: 27593868
[TBL] [Abstract][Full Text] [Related]
35. Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome.
Hurd WW; Abdel-Rahman MY; Ismail SA; Abdellah MA; Schmotzer CL; Sood A
Fertil Steril; 2011 Oct; 96(4):1043-7. PubMed ID: 21813121
[TBL] [Abstract][Full Text] [Related]
36. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
37. Obesity's Influence on Insulin Resistance in Pregnant Women with Polycystic Ovary Syndrome.
Eto E; Tani K; Maki J; Hayata K; Masuyama H
Acta Med Okayama; 2022 Feb; 76(1):51-56. PubMed ID: 35236998
[TBL] [Abstract][Full Text] [Related]
38. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
[TBL] [Abstract][Full Text] [Related]
39. [Comparative diagnostic characteristics of carbohydrate metabolism disorders in women with polycystic ovary syndrome (PCOS)].
Orbetsova M; Orbetsova V; Kamenov Z; Kolarov G; Andreeva M; Genchev G; Zakharieva S; Borisov I
Akush Ginekol (Sofiia); 2003; 42(4):10-5. PubMed ID: 14577361
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of HOMA IR with the minimal model for measuring insulin sensitivity in polycystic ovary syndrome].
Amador N; Espinoza G; Guízar JM; González M; Alpízar M
Rev Invest Clin; 2001; 53(5):407-12. PubMed ID: 11795106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]